Dechra Pharmaceuticals PLC Director/PDMR Shareholdings (7894M)
18 September 2019 - 6:32PM
UK Regulatory
TIDMDPH
RNS Number : 7894M
Dechra Pharmaceuticals PLC
18 September 2019
18 September 2019
Dechra Pharmaceuticals PLC
Notification of Transactions by Persons Discharging Managerial
Responsibilities
On 17 September 2019, Dechra Pharmaceuticals PLC was notified by
Directors of the Company and Persons Discharging Managerial
Responsibilities that they had completed the sale of part of their
beneficial interest in Dechra.
Ian Page, Executive Director and Tony Rice, Non-Executive
Chairman, have sold 200,000 ordinary shares and 20,000 ordinary
shares respectively in the Company to satisfy long term personal
financial planning considerations and widen their investment
portfolios. The shares have been placed in the market with
investors. Following these transactions, Ian Page will continue to
retain a beneficial holding of 586,650 which represents 0.571% and
Tony Rice, 20,000 representing 0.019% of the current issued share
capital in the Company.
The Notification of Dealing Forms set out below are provided in
accordance with Article 19.3 of MAR.
Notification of Dealing Form:
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
------------------------------------- ----------------------------------
2. Reason for the notification
-------------------------------------------------------------------------
a) Position/status Director
------------------------------------- ----------------------------------
b) Initial notification/amendment Initial Notification
------------------------------------- ----------------------------------
3. Details of the Issuer
-------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------- ----------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
-------------------------------------------------------------------------
a) Description of the financial Ordinary Shares of 1 pence each
instrument ISIN: GB0009633180
Identification code
------------------------------------- ----------------------------------
b) Nature of the transaction Sale of Shares
------------------------------------- ----------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP29.1695 200,000
------------------------------------- ------------------ --------------
d) Aggregated information
* Aggregate volume 200,000
GBP29.1695
GBP5,833,900
* Price
* Total
------------------------------------- ----------------------------------
e) Date of the transaction 17 September 2019
------------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange
------------------------------------- ----------------------------------
Notification of Dealing Form:
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Rice
------------------------------------ ----------------------------------
2. Reason for the notification
------------------------------------------------------------------------
a) Position/status Director
------------------------------------ ----------------------------------
b) Initial notification/amendment Initial Notification
------------------------------------ ----------------------------------
3. Details of the Issuer
------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------ ----------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------ ----------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
------------------------------------------------------------------------
a) Description of the financial Ordinary Shares of 1 pence each
instrument ISIN: GB0009633180
Identification code
------------------------------------ ----------------------------------
b) Nature of the transaction Sale of Shares
------------------------------------ ----------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP29.09968 20,000
------------------------------------ ------------------- -------------
d) Aggregated information
* Aggregate volume 20,000
GBP29.09968
GBP581,993.60
* Price
* Total
------------------------------------ ----------------------------------
e) Date of the transaction 17 September 2019
------------------------------------ ----------------------------------
f) Place of the transaction London Stock Exchange
------------------------------------ ----------------------------------
Enquiries:
Dechra Pharmaceuticals PLC
Ishbel Macpherson, Senior Office: +44 (0) 1606 814 730
Independent Director
Ian Page, Chief Executive Office: +44 (0) 1606 814 730
Officer
Paul Sandland, Acting Chief Office: +44 (0) 1606 814 730
Financial Officer
e-mail: corporate.enquiries@dechra.com
TooleyStreet Communications
Ltd
Fiona Tooley, Director Office: +44 (0) 121 309 0099
e-mail: fiona@tooleystreet.com Mobile: +44 (0) 7785 703 523
---------------------------------------- ------------------------------
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and
related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. Dechra's business is
unique as the majority of its products are used to treat medical
conditions for which there is no other effective solution or have a
clinical or dosing advantage over competitor products. For more
information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of
Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHSFMSAAFUSEEU
(END) Dow Jones Newswires
September 18, 2019 04:32 ET (08:32 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024